Display options
Share it on

Ann Transl Med. 2016 Dec;4(24):501. doi: 10.21037/atm.2016.12.11.

Attempting to define and refine vasopressin use in septic shock: the VANISH trial.

Annals of translational medicine

Aviral Roy, Richard Phillip Dellinger

Affiliations

  1. Division of Critical Care, Department of Medicine, Cooper Medical School of Rowan University, Cooper University Health Care, Camden, New Jersey, USA.

PMID: 28149863 PMCID: PMC5233516 DOI: 10.21037/atm.2016.12.11

[No abstract available.]

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

  1. Germs. 2015 Mar 02;5(1):17-25 - PubMed
  2. Intensive Care Med. 2012 Jan;38(1):9-19 - PubMed
  3. N Engl J Med. 2008 Feb 28;358(9):877-87 - PubMed
  4. Crit Care. 2012 Aug 14;16(4):R154 - PubMed
  5. Crit Care Med. 2014 Jun;42(6):1325-33 - PubMed
  6. Intensive Care Med. 2010 Jan;36(1):83-91 - PubMed
  7. Crit Care Med. 2009 Mar;37(3):811-8 - PubMed
  8. Crit Care. 2011 Aug 11;15(4):226 - PubMed
  9. Can J Physiol Pharmacol. 2016 Jun 24;:1-10 - PubMed
  10. JAMA. 2013 Aug 14;310(6):591-608 - PubMed
  11. JAMA. 2016 Aug 2;316(5):509-18 - PubMed
  12. Clin J Am Soc Nephrol. 2007 May;2(3):431-9 - PubMed
  13. Crit Care Med. 2012 Mar;40(3):754-61 - PubMed
  14. Intensive Care Med. 2008 Jan;34(1):17-60 - PubMed
  15. JAMA. 1995 Jan 11;273(2):117-23 - PubMed
  16. Anesthesiology. 2002 Mar;96(3):576-82 - PubMed
  17. Circulation. 1997 Mar 4;95(5):1122-5 - PubMed
  18. Intensive Care Med. 2001 Aug;27(8):1416-21 - PubMed

Publication Types